A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 76,324 shares of REGN stock, worth $50.9 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
76,324
Previous 77,928 2.06%
Holding current value
$50.9 Million
Previous $81.9 Million 2.04%
% of portfolio
0.18%
Previous 0.2%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1024.09 - $1201.76 $1.64 Million - $1.93 Million
-1,604 Reduced 2.06%
76,324 $80.2 Million
Q2 2024

Aug 08, 2024

SELL
$883.2 - $1071.19 $6.95 Million - $8.42 Million
-7,865 Reduced 9.17%
77,928 $81.9 Million
Q1 2024

May 10, 2024

SELL
$902.69 - $993.35 $3.32 Million - $3.65 Million
-3,678 Reduced 4.11%
85,793 $82.6 Million
Q4 2023

Feb 09, 2024

SELL
$775.18 - $881.7 $754,250 - $857,894
-973 Reduced 1.08%
89,471 $78.6 Million
Q3 2023

Nov 09, 2023

SELL
$692.45 - $844.37 $31.9 Million - $39 Million
-46,138 Reduced 33.78%
90,444 $74.4 Million
Q2 2023

Aug 08, 2023

SELL
$700.03 - $830.35 $168,707 - $200,114
-241 Reduced 0.18%
136,582 $98.1 Million
Q1 2023

May 10, 2023

SELL
$680.49 - $826.97 $11 Million - $13.4 Million
-16,209 Reduced 10.59%
136,823 $112 Million
Q4 2022

Feb 10, 2023

SELL
$705.89 - $766.39 $17.8 Million - $19.3 Million
-25,220 Reduced 14.15%
153,032 $110 Million
Q3 2022

Nov 10, 2022

SELL
$573.97 - $724.32 $9.22 Million - $11.6 Million
-16,072 Reduced 8.27%
178,252 $123 Million
Q2 2022

Aug 09, 2022

BUY
$548.35 - $738.84 $4.77 Million - $6.43 Million
8,699 Added 4.69%
194,324 $115 Million
Q1 2022

May 12, 2022

SELL
$595.12 - $698.43 $1.2 Million - $1.4 Million
-2,009 Reduced 1.07%
185,625 $130 Million
Q4 2021

Feb 09, 2022

BUY
$543.48 - $670.97 $8.72 Million - $10.8 Million
16,040 Added 9.35%
187,634 $118 Million
Q3 2021

Nov 12, 2021

BUY
$574.03 - $680.96 $1.64 Million - $1.95 Million
2,860 Added 1.69%
171,594 $104 Million
Q2 2021

Aug 12, 2021

SELL
$472.8 - $558.54 $2.46 Million - $2.91 Million
-5,207 Reduced 2.99%
168,734 $93.3 Million
Q1 2021

May 12, 2021

BUY
$446.73 - $548.2 $15.4 Million - $19 Million
34,568 Added 24.8%
173,941 $82.9 Million
Q4 2020

Feb 12, 2021

BUY
$478.3 - $607.98 $6.2 Million - $7.88 Million
12,959 Added 10.25%
139,373 $67.3 Million
Q3 2020

Nov 12, 2020

BUY
$544.75 - $658.21 $80,078 - $96,756
147 Added 0.12%
126,414 $70.8 Million
Q2 2020

Sep 11, 2020

SELL
$493.32 - $643.92 $5.6 Million - $7.31 Million
-11,358 Reduced 8.25%
126,267 $78.7 Million
Q2 2020

Aug 13, 2020

BUY
$493.32 - $643.92 $29 Million - $37.9 Million
58,850 Added 74.71%
137,625 $78.7 Million
Q1 2020

May 13, 2020

BUY
$336.18 - $494.43 $1.45 Million - $2.13 Million
4,303 Added 5.78%
78,775 $38.5 Million
Q4 2019

Feb 14, 2020

BUY
$274.13 - $376.51 $46,602 - $64,006
170 Added 0.23%
74,472 $28 Million
Q3 2019

Nov 12, 2019

BUY
$273.46 - $318.39 $415,112 - $483,316
1,518 Added 2.09%
74,302 $20.3 Million
Q2 2019

Aug 07, 2019

BUY
$299.6 - $414.82 $1.34 Million - $1.85 Million
4,468 Added 6.54%
72,784 $22.6 Million
Q1 2019

May 13, 2019

BUY
$372.08 - $439.57 $801,088 - $946,394
2,153 Added 3.25%
68,316 $27.7 Million
Q4 2018

Feb 12, 2019

BUY
$335.82 - $403.04 $942,646 - $1.13 Million
2,807 Added 4.43%
66,163 $24.7 Million
Q3 2018

Nov 13, 2018

SELL
$351.14 - $408.51 $35.9 Million - $41.7 Million
-102,123 Reduced 61.71%
63,356 $25.6 Million
Q2 2018

Aug 10, 2018

BUY
$284.6 - $344.99 $712,353 - $863,509
2,503 Added 1.54%
165,479 $57.1 Million
Q1 2018

May 11, 2018

BUY
$315.82 - $393.78 $1.46 Million - $1.83 Million
4,636 Added 2.93%
162,976 $56.1 Million
Q4 2017

Feb 09, 2018

BUY
$358.63 - $469.95 $48,773 - $63,913
136 Added 0.09%
158,340 $59.5 Million
Q3 2017

Nov 13, 2017

BUY
$431.38 - $504.0 $68.2 Million - $79.7 Million
158,204
158,204 $70.7 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $71.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Mitsubishi Ufj Trust & Banking Corp Portfolio

Follow Mitsubishi Ufj Trust & Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.